S&P 500 7,551.81 −0.45%
Nasdaq 25,978.42 −0.01%
S&P/TSX 35,491.27 −0.26%
Apple 332.41 +0.32%
Nvidia 213.90 +0.82%
Microsoft 490.30 −1.37%
Shopify 181.77 +0.54%
Royal Bank 283.06 −0.40%
CAD/USD 0.7148 −0.47%
PRE-MKT · 08:25 ET
Market ClerkRecap
Thu Sep 17 · pre-market3 signals today312 insider buys this week · $295.5MCIRO short report next: Sep 30The week ahead

HIND

Vyome Holdings, Inc
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
1.95
−0.06 −2.99%
USD · close Sep 16

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Financials

SEC XBRL · 58 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$27K−46.0%43.2%−$863K−$686K-0.10−$904KAug 12
Q1 2026 · Mar 31$32K−84.1%52.7%−$1.1M−$963K-0.15−$1.4MMay 12
Q4 2025 · Dec 31derived$37K−40.5%60.4%−$1.4M−$1.2M5.14−$1.5MMar 18
Q3 2025 · Sep 30$35K−59.0%52.1%−$8.6M−$8.4M-3.12−$1.8MNov 14
Q2 2025 · Jun 30$50K−97.5%48.5%−$324K−$309K-799.90−$306KAug 12
Q1 2025 · Mar 31$199K−89.8%77.8%−$199K−$294K-761.59−$204KMay 12
Q4 2024 · Dec 31derived$61K−96.9%102.2%−$256K−$307K-3045.68−$3KMar 18
Q3 2024 · Sep 30$85K−96.1%43.9%−$281K−$548K-1419.10$2.8MNov 14
Q2 2024 · Jun 30$2M57.7%−$2.1M−$1.6M-91.56−$1.4MAug 14
Q1 2024 · Mar 31$1.9M59.9%−$2.2M−$2.2M-135.37−$2.1MMay 20
Q4 2023 · Dec 31derived$2M92.9%−$1.9M−$1.7M89.11−$2.5M$0−$2.5MApr 4
Q3 2023 · Sep 30$2.2M59.8%−$3.9M−$3.5M-59.36−$2.8M$0−$2.8MNov 14

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$320K68.4%−$10.5M−$10.3M-3209.7%-4.86−$3.7M
FY2024 · to Dec 31$257K75.9%−$1M−$1.4M-563.3%-6001.39−$614K
FY2023 · to Dec 31$8.7M63.9%−$15.4M−$11.4M-131.2%-110.87−$17M$43K−$17M
FY2022 · to Dec 31$11.2M60.5%−$46.4M−$46.2M-411.2%-108.90−$21.9M$131K−$22M
FY2021 · to Dec 31$13.6M61.4%−$57.9M−$63.1M-464.3%-288.97−$15.4M$352K−$15.7M
FY2020 · to Dec 31$11.3M55.4%−$12.5M−$21.6M-191.4%-5.55−$8.6M$171K−$8.7M

Every number comes from Vyome Holdings, Inc's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch HIND. Know when insiders buy.
One email the day a filing lands. Free.